ATLAS-1: Longitudinal assessment of treatments for depressed mood
Official title: ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Run by Salma Health, Inc. · NCT07528014 · Data updated 2026-11-12
This project will try to use clinical data from adults with depressed mood who receive esketamine, conventional TMS, or SAINT to build tools that predict which treatment is most likely to help.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Salma Health, Inc. Academic / other |
| Locations | 2 sites (La Jolla, California and 1 other locations) |
| Status | Recruiting |
| Started | March 25, 2026 |
| Main results expected | March 2036 |
| Study ends | March 2037 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07528014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older presenting with depressed mood who are prescribed esketamine, conventional TMS, or SAINT and can provide informed consent are ideal candidates.
✕Probably not a fit
People who are not receiving those specific treatments, are under 18, or have conditions that prevent safe participation in the study assessments may not benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects multimodal clinical data from adults treated for depressed mood in routine care at two Salma Health clinics and may incorporate authorized retrospective data from existing databases. Participants will be those prescribed esketamine, conventional transcranial magnetic stimulation (TMS), or Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) as part of standard care, with data used to develop and validate predictive models of treatment response. The approach focuses on real-world clinical measurements rather than experimental interventions and emphasizes model training and validation across available datasets. Outcomes will include model performance metrics and the feasibility of integrating such tools to inform treatment selection.
Why it matters
Potential benefit: If successful, the models could help clinicians choose the most promising treatment sooner, reducing trial-and-error and speeding relief for patients.
How similar studies have gone: Prior research using predictive models for TMS and ketamine-like therapies has shown promise in controlled settings, but these approaches remain experimental and need validation in real-world clinical datasets.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) of any gender identity presenting for care with a depressed mood. * Prescribed treatment with esketamine, conventional TMS, or SAINT as part of standard clinical care. * Able to provide informed consent and comply with all study requirements. Exclusion Criteria: * Any condition deemed by the investigator to preclude safe participation in study assessments.
Where it's running
-
Salma Health
La Jolla, California, United States Recruiting -
Salma Health
Laguna Hills, California, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heat and Mood in Young Adults with Depression
This study tests whether hot indoor environments affect mood in young adults with depression and whether daytime heat harms mood more than nighttime heat.
-
Behavioral Activation for Depression in Autistic Teens with Below-Average IQ
This study tests a tailored behavioral activation approach to see if it helps reduce depressive symptoms in autistic adolescents who have below-average cognitive abilities.
-
Digital twins to classify mental health patterns in adults with diabetes
This project will try to create 'digital twin' profiles that combine glucose, mood, and behavior data to track mental health patterns in adults with diabetes.
-
Cognitive behavioral therapy plus mindfulness program to help people adjust to vision loss
This project will try an 8-week group program combining cognitive behavioral therapy and mindfulness for adults adjusting to vision loss.
-
Telehealth exercise program to treat depression after brain injury
This study tests whether a telehealth exercise program can help people with depression after a brain injury feel better by encouraging them to be more active.
-
Exploring logotherapy's effects on mood disorders in adolescents
This study is testing if logotherapy can help improve mood and reduce feelings of depression and anxiety in teenagers with mood disorders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.